Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134562) titled 'Efficacy and Safety of Romiplostim in Promoting Platelet Engraftment in Patients Undergoing Allogeneic Transplantation' on Oct. 16.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhejiang Provincial Hospital of TCM
Condition:
Blood system diseases
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2024-11-05
Target Sample Size: Romiplostim treatment Group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=342068
Disclaimer: Curated by HT Syndication....